Abrey, Lauren E.

Selected publications

Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. Journal of Neuro-Oncology. 2019 Academic Article GET IT
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer. Cancer. 2015 Academic Article GET IT
Times cited: 11
Radiotherapy and temozolomide for anaplastic astrocytic gliomas. Journal of Neuro-Oncology. 2015 Academic Article GET IT
Times cited: 3
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 118
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro-Oncology. 2015 Academic Article GET IT
Times cited: 92
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clinical Cancer Research. 2014 Academic Article GET IT
Times cited: 42
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: Final results and long-term outcome. Journal of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 180
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma. International Journal of Radiation Oncology Biology Physics. 2013 Academic Article GET IT
Times cited: 43
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology. 2013 Academic Article GET IT
Times cited: 57
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leukemia and Lymphoma. 2013 Academic Article GET IT
Times cited: 35
Post-treatment T1 shortening in primary CNS lymphoma. Journal of Neuro-Oncology. 2013 Academic Article GET IT
Times cited: 1
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer. 2012 Academic Article GET IT
Times cited: 57
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro-Oncology. 2012 Academic Article GET IT
Times cited: 41
Response to Weltman and Fleury Malheiros, re Lassman et al. Neuro-Oncology. 2012 Information Resource GET IT
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-Oncology. 2012 Academic Article GET IT
Times cited: 105
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. Journal of Neuro-Oncology. 2011 Academic Article GET IT
Times cited: 15
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro-Oncology. 2011 Academic Article GET IT
Times cited: 48
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy. Leukemia and Lymphoma. 2011 Academic Article GET IT
Times cited: 8
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma. Annals of Neurology. 2011 Academic Article GET IT
Times cited: 21
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-Oncology. 2011 Academic Article GET IT
Times cited: 104
Late relapse in primary central nervous system lymphoma: Clonal persistence. Neuro-Oncology. 2011 Academic Article GET IT
Times cited: 25
Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma. Medical Physics. 2011 Academic Article GET IT
Times cited: 4
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches. Radiation Oncology. 2011 Review GET IT
Times cited: 68
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center experience. Cancer. 2010 Academic Article GET IT
Times cited: 36
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro-Oncology. 2010 Academic Article GET IT
Times cited: 123
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro-Oncology. 2010 Academic Article GET IT
Times cited: 29
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncology. 2010 Academic Article GET IT
Times cited: 166
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. Journal of Neuro-Oncology. 2010 Academic Article GET IT
Times cited: 96
Neurological outcome of long-term glioblastoma survivors. Journal of Neuro-Oncology. 2009 Academic Article GET IT
Times cited: 54
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-Oncology. 2009 Academic Article GET IT
Times cited: 81
Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas. International Journal of Radiation Oncology Biology Physics. 2009 Academic Article GET IT
Times cited: 256
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Journal of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 126
Prognosis and patterns of care in elderly patients with glioma. Cancer. 2009 Academic Article GET IT
Times cited: 30
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). Journal of Neuro-Oncology. 2009 Academic Article GET IT
Times cited: 125
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. Journal of Neuro-Oncology. 2009 Academic Article GET IT
Times cited: 74
Utility of brain FDG-PET in primary CNS lymphoma. Clinical Advances in Hematology and Oncology. 2008 Academic Article GET IT
Times cited: 25
Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma. Leukemia and Lymphoma. 2008 Academic Article GET IT
Times cited: 16
Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer. 2008 Academic Article GET IT
Times cited: 58
Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium. Neuro-Oncology. 2008 Review GET IT
Times cited: 24
The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-Oncology. 2008 Academic Article GET IT
Times cited: 84
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. Journal of Neuro-Oncology. 2008 Academic Article GET IT
Times cited: 38
Imaging of Lymphoma of the Central Nervous System, Spine, and Orbit. Radiologic Clinics of North America. 2008 Review GET IT
Times cited: 43
Longitudinal cognitive follow-up in low grade gliomas. Journal of Neuro-Oncology. 2008 Academic Article GET IT
Times cited: 66
Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer. 2008 Academic Article GET IT
Times cited: 57
Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma. Cancer. 2007 Academic Article GET IT
Times cited: 33
Capecitabine therapy of central nervous system metastases from breast cancer. Journal of Neuro-Oncology. 2007 Academic Article GET IT
Times cited: 97
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas. Journal of Neuro-Oncology. 2007 Academic Article GET IT
Times cited: 9
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. Journal of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 258
In reply [9]. Journal of Clinical Oncology. 2007 Information Resource GET IT
Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer. 2007 Academic Article GET IT
Times cited: 33
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology. 2007 Academic Article GET IT
Times cited: 115
Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro-Oncology. 2007 Academic Article GET IT
Times cited: 86
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. Journal of Neuro-Oncology. 2007 Academic Article GET IT
Times cited: 50
Chemoradiotherapy for primary CNS lymphoma. Progress in Neurotherapeutics and Neuropsychopharmacology. 2007 Academic Article GET IT
Primary central nervous system lymphoma: The memorial sloan-kettering cancer center prognostic model. Journal of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 292
Retinopathy in survivors of primary central nervous system lymphoma. Neurology. 2006 Academic Article GET IT
Times cited: 5
Familial central nervous system tumor syndromes. Current Cancer Therapy Reviews. 2006 Report GET IT
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. Journal of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 191
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clinical Cancer Research. 2006 Academic Article GET IT
Times cited: 312
Primary dural lymphomas: A clinicopathologic study of treatment and outcome in eight patients. Neurology. 2006 Academic Article GET IT
Times cited: 61
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up. Neuro-Oncology. 2006 Academic Article GET IT
Times cited: 36
Imaging neurotoxicity: Is a picture worth a thousand words?. American Journal of Neuroradiology. 2005 Article GET IT
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. Journal of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 402
Salvage temozolomide for prior temozolomide responders. Cancer. 2005 Academic Article GET IT
Times cited: 69
Trends in survival from primary central nervous system lymphoma, 1975-1999: A population-based analysis. Cancer. 2005 Academic Article GET IT
Times cited: 83
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium trials 01-03 and 00-01. Clinical Cancer Research. 2005 Academic Article GET IT
Times cited: 189
Delayed neurotoxicity in primary central nervous system lymphoma. Archives of Neurology. 2005 Academic Article GET IT
Times cited: 157
Leukemic and lymphomatous meningitis: Incidence, Prognosis and treatment. Journal of Neuro-Oncology. 2005 Review GET IT
Times cited: 54
Central nervous system lymphomas. Hematology/Oncology Clinics of North America. 2005 Editorial Article GET IT
Treatment-related neurotoxicity. Hematology/Oncology Clinics of North America. 2005 Review GET IT
Times cited: 10
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer. 2005 Academic Article GET IT
Times cited: 180
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide [6] (multiple letters). Neurology. 2005 Article GET IT
Times cited: 1
Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up. Neurology. 2005 Academic Article GET IT
Times cited: 67
Diagnosis and treatment of primary central nervous system lymphoma. Current Oncology Reports. 2005 Review GET IT
Times cited: 6
Leptomeningeal metastases from leukemias and lymphomas. Cancer treatment and research. 2005 Review GET IT
Times cited: 10
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2004 Review GET IT
Times cited: 156
Primary central nervous system lymphoma. Current Oncology Reports. 2004 Review GET IT
Times cited: 6
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer. 2004 Academic Article GET IT
Times cited: 128
Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study. Neurology. 2004 Review GET IT
Times cited: 118
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis. Journal of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 218
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. Journal of Neuro-Oncology. 2003 Academic Article GET IT
Times cited: 27
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings. Clinical Advances in Hematology and Oncology. 2003 Academic Article GET IT
Times cited: 9
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. Journal of Clinical Oncology. 2003 Article GET IT
Times cited: 128
Lymphomatous meningitis: Incidence, prognosis and treatment. American Journal of Cancer. 2002 Report GET IT
Times cited: 2
High-grade gliomas in patients with prior systemic malignancies. Cancer. 2002 Academic Article GET IT
Times cited: 17
Treatment for primary CNS lymphoma: The next step. Journal of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 492
High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors. Journal of Neuro-Oncology. 1999 Academic Article GET IT
Times cited: 32
Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth. Clinical Cancer Research. 1999 Academic Article GET IT
Times cited: 16
Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy. Journal of Neuro-Oncology. 1998 Academic Article GET IT
Times cited: 19
Long-term survival in primary CNS lymphoma. Journal of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 433

VIVO Weill Cornell Medical College

Abrey, Lauren E. External Author

Publications

Selected publications